|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Choi JH, Wong AS, Huang HF and Leung PC:
Gonadotropins and ovarian cancer. Endocr Rev. 28:440–461. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ozols RF: Systemic therapy for ovarian
cancer: Current status and new treatments. Semin Oncol. 33:(Suppl
6). S3–S11. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Agarwal R and Kaye SB: Ovarian cancer:
Strategies for overcoming resistance to chemotherapy. Nat Rev
Cancer. 3:502–516. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mabuchi S, Kuroda H, Takahashi R and
Sasano T: The PI3K/AKT/mTOR pathway as a therapeutic target in
ovarian cancer. Gynecol Oncol. 137:173–179. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Arend RC, Londoño-Joshi AI, Straughn JM Jr
and Buchsbaum DJ: The Wnt/β-catenin pathway in ovarian cancer: A
review. Gynecol Oncol. 131:772–779. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Takebe N, Harris PJ, Warren RQ and Ivy SP:
Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog
pathways. Nat Rev Clin Oncol. 8:97–106. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Park JT, Li M, Nakayama K, Mao TL,
Davidson B, Zhang Z, Kurman RJ, Eberhart CG, Shih IeM and Wang TL:
Notch3 gene amplification in ovarian cancer. Cancer Res.
66:6312–6318. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rose SL, Kunnimalaiyaan M, Drenzek J and
Seiler N: Notch 1 signaling is active in ovarian cancer. Gynecol
Oncol. 117:130–133. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liao X, Siu MK, Au CW, Wong ES, Chan HY,
Ip PP, Ngan HY and Cheung AN: Aberrant activation of hedgehog
signaling pathway in ovarian cancers: Effect on prognosis, cell
invasion and differentiation. Carcinogenesis. 30:131–140. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Artavanis-Tsakonas S, Rand MD and Lake RJ:
Notch signaling: Cell fate control and signal integration in
development. Science. 284:770–776. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dang TP: Notch, apoptosis and cancer. Adv
Exp Med Biol. 727:199–209. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Weng AP, Ferrando AA, Lee W, Morris JP IV,
Silverman LB, Sanchez-Irizarry C, Blacklow SC, Look AT and Aster
JC: Activating mutations of NOTCH1 in human T cell acute
lymphoblastic leukemia. Science. 306:269–271. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Westhoff B, Colaluca IN, D'Ario G,
Donzelli M, Tosoni D, Volorio S, Pelosi G, Spaggiari L, Mazzarol G,
Viale G, et al: Alterations of the Notch pathway in lung cancer.
Proc Natl Acad Sci USA. 106:22293–22298. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stylianou S, Clarke RB and Brennan K:
Aberrant activation of notch signaling in human breast cancer.
Cancer Res. 66:1517–1525. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rose SL: Notch signaling pathway in
ovarian cancer. Int J Gynecol Cancer. 19:564–566. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rahman MT, Nakayama K, Rahman M, Katagiri
H, Katagiri A, Ishibashi T, Ishikawa M, Iida K, Nakayama S, Otsuki
Y, et al: Notch3 overexpression as potential therapeutic target in
advanced stage chemoresistant ovarian cancer. Am J Clin Pathol.
138:535–544. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sanchez GM, Re L, Giuliani A, Núñez-Sellés
AJ, Davison GP and León-Fernández OS: Protective effects of
Mangifera indica L. extract, mangiferin and selected
antioxidants against TPA-induced biomolecules oxidation and
peritoneal macrophage activation in mice. Pharmacol Res.
42:565–573. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dar A, Faizi S, Naqvi S, Roome T,
Zikr-ur-Rehman S, Ali M, Firdous S and Moin ST: Analgesic and
antioxidant activity of mangiferin and its derivatives: The
structure activity relationship. Biol Pharm Bull. 28:596–600. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guha S, Ghosal S and Chattopadhyay U:
Antitumor, immunomodulatory and anti-HIV effect of mangiferin, a
naturally occurring glucosylxanthone. Chemotherapy. 42:443–451.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Duang XY, Wang Q, Zhou XD and Huang DM:
Mangiferin: A possible strategy for periodontal disease to therapy.
Med Hypotheses. 76:486–488. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
García-Rivera D, Delgado R, Bougarne N,
Haegeman G and Berghe WV: Gallic acid indanone and mangiferin
xanthone are strong determinants of immunosuppressive anti-tumour
effects of Mangifera indica L. bark in MDA-MB231 breast
cancer cells. Cancer Lett. 305:21–31. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Noratto GD, Bertoldi MC, Krenek K, Talcott
ST, Stringheta PC and Mertens-Talcott SU: Anticarcinogenic effects
of polyphenolics from mango (Mangifera indica) varieties. J
Agric Food Chem. 58:4104–4112. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chieli E, Romiti N, Rodeiro I and Garrido
G: In vitro effects of Mangifera indica and polyphenols
derived on ABCB1/P-glycoprotein activity. Food Chem Toxicol.
47:2703–2710. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cheng P, Peng ZG, Yang J and Song SJ: The
effect of mangiferin on telomerase activity and apoptosis in
leukemic K562 cells. Zhong Yao Cai. 30:306–309. 2007.(In Chinese).
PubMed/NCBI
|
|
26
|
Peng ZG, Luo J, Xia LH, Chen Y and Song
SJ: CML cell line K562 cell apoptosis induced by mangiferin.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 12:590–594. 2004.(In Chinese).
PubMed/NCBI
|
|
27
|
Percival SS, Talcott ST, Chin ST, Mallak
AC, Lounds-Singleton A and Pettit-Moore J: Neoplastic
transformation of BALB/3T3 cells and cell cycle of HL-60 cells are
inhibited by mango (Mangifera indica L.) juice and mango
juice extracts. J Nutr. 136:1300–1304. 2006.PubMed/NCBI
|
|
28
|
Chari NS, Pinaire NL, Thorpe L, Medeiros
LJ, Routbort MJ and McDonnell TJ: The p53 tumor suppressor network
in cancer and the therapeutic modulation of cell death. Apoptosis.
14:336–347. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li H, Huang J, Yang B, Xiang T, Yin X,
Peng W, Cheng W, Wan J, Luo F, Li H, et al: Mangiferin exerts
antitumor activity in breast cancer cells by regulating matrix
metalloproteinases, epithelial to mesenchymal transition, and
β-catenin signaling pathway. Toxicol Appl Pharmacol. 272:180–190.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shi W, Deng J, Tong R, Yang Y, He X, Lv J,
Wang H, Deng S, Qi P, Zhang D, et al: Molecular mechanisms
underlying mangiferin-induced apoptosis and cell cycle arrest in
A549 human lung carcinoma cells. Mol Med Rep. 13:3423–3432.
2016.PubMed/NCBI
|
|
31
|
Ozols RF, Bundy BN, Greer BE, Fowler JM,
Clarke-Pearson D, Burger RA, Mannel RS, DeGeest K, Hartenbach EM,
Baergen R, et al: Gynecologic Oncology Group: Phase III trial of
carboplatin and paclitaxel compared with cisplatin and paclitaxel
in patients with optimally resected stage III ovarian cancer: A
Gynecologic Oncology Group study. J Clin Oncol. 21:3194–3200. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Luo X, Budihardjo I, Zou H, Slaughter C
and Wang X: Bid, a Bcl2 interacting protein, mediates cytochrome c
release from mitochondria in response to activation of cell surface
death receptors. Cell. 94:481–490. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Worsley SD, Ponder BA and Davies BR:
Overexpression of cyclin D1 in epithelial ovarian cancers. Gynecol
Oncol. 64:189–195. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yao J and Qian C: Inhibition of Notch3
enhances sensitivity to gemcitabine in pancreatic cancer through an
inactivation of PI3K/Akt-dependent pathway. Med Oncol.
27:1017–1022. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sarkar A, Sreenivasan Y, Ramesh GT and
Manna SK: beta-D-Glucoside suppresses tumor necrosis factor-induced
activation of nuclear transcription factor kappaB but potentiates
apoptosis. J Biol Chem. 279:33768–33781. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Rajendran P, Ekambaram G and Sakthisekaran
D: Protective role of mangiferin against Benzo(a)pyrene induced
lung carcinogenesis in experimental animals. Biol Pharm Bull.
31:1053–1058. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Allenspach EJ, Maillard I, Aster JC and
Pear WS: Notch signaling in cancer. Cancer Biol Ther. 1:466–476.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nickoloff BJ, Osborne BA and Miele L:
Notch signaling as a therapeutic target in cancer: A new approach
to the development of cell fate modifying agents. Oncogene.
22:6598–6608. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang M, Wu L, Wang L and Xin X:
Down-regulation of Notch1 by gamma-secretase inhibition contributes
to cell growth inhibition and apoptosis in ovarian cancer cells
A2780. Biochem Biophys Res Commun. 393:144–149. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Drenzek JG, Seiler NL, Jaskula-Sztul R,
Rausch MM and Rose SL: Xanthohumol decreases Notch1 expression and
cell growth by cell cycle arrest and induction of apoptosis in
epithelial ovarian cancer cell lines. Gynecol Oncol. 122:396–401.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu MX, Siu MK, Liu SS, Yam JW, Ngan HY
and Chan DW: Epigenetic silencing of microRNA-199b-5p is associated
with acquired chemoresistance via activation of JAG1-Notch1
signaling in ovarian cancer. Oncotarget. 5:944–958. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Park JT, Chen X, Tropè CG, Davidson B,
Shih IeM and Wang TL: Notch3 overexpression is related to the
recurrence of ovarian cancer and confers resistance to carboplatin.
Am J Pathol. 177:1087–1094. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gupta N, Xu Z, El-Sehemy A, Steed H and Fu
Y: Notch3 induces epithelial-mesenchymal transition and attenuates
carboplatin-induced apoptosis in ovarian cancer cells. Gynecol
Oncol. 130:200–206. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
McAuliffe SM, Morgan SL, Wyant GA, Tran
LT, Muto KW, Chen YS, Chin KT, Partridge JC, Poole BB, Cheng KH, et
al: Targeting Notch, a key pathway for ovarian cancer stem cells,
sensitizes tumors to platinum therapy. Proc Natl Acad Sci USA.
109:E2939–E2948. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Choi JH, Park JT, Davidson B, Morin PJ, Ie
M Shih and Wang TL: Jagged-1 and Notch3 juxtacrine loop regulates
ovarian tumor growth and adhesion. Cancer Res. 68:5716–5723. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chen X, Stoeck A, Lee SJ, Shih IeM, Wang
MM and Wang TL: Jagged1 expression regulated by Notch3 and
Wnt/β-catenin signaling pathways in ovarian cancer. Oncotarget.
1:210–218. 2010. View Article : Google Scholar : PubMed/NCBI
|
